Header cover image
  • Investing Ideas
  • /
  • Greek Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Greek Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Results

1

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

1 companies

Lavipharm

Market Cap: €136.0m

Engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally.

LAVI

€0.81

7D

2.9%

1Y

-12.1%